论文部分内容阅读
目的观察更昔洛韦联合利巴韦林治疗巨细胞病毒性肝炎的临床效果。方法收集近4年治疗的巨细胞病毒性肝炎43例分为两组,治疗组患儿采用更昔洛韦联合利巴韦林治疗,对照组予以更昔洛韦治疗。结果治疗组总有效率为95.56%,对照组为78.57%,差异有显著性(P<0.05)。结论更昔洛韦联合利巴韦林治疗巨细胞病毒性肝炎效果好,值得临床推广应用。
Objective To observe the clinical effect of ganciclovir combined with ribavirin in the treatment of cytomegalovirus hepatitis. Methods Forty-three cases of cytomegalovirus hepatitis treated in the recent 4 years were divided into two groups. The patients in the treatment group were treated with ganciclovir and ribavirin, while the control group was treated with ganciclovir. Results The total effective rate was 95.56% in the treatment group and 78.57% in the control group, the difference was significant (P <0.05). Conclusion Ganciclovir combined with ribavirin in the treatment of cytomegalovirus is effective and worthy of clinical application.